Back to Search
Start Over
APPLICATION OF TICAGRELOR OR CLOPIDOGREL BASED DUAL ANTIPLATELET THERAPY FOLLOWING A PHARMACOINVASIVE STRATEGY IN ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION: INSIGHTS FROM THE VITAL HEART RESPONSE REGISTRY
- Source :
- Journal of the American College of Cardiology. 73:243
- Publication Year :
- 2019
- Publisher :
- Elsevier BV, 2019.
-
Abstract
- Ticagrelor (TIC) based dual antiplatelet therapy (DAPT) is standard of care for acute coronary syndromes (ACS) with the exception of fibrinolysis treated ST-segment elevation myocardial infarction (STEMI) patients where clopidogrel (CLOP) is recommended. Although comparable 30-day safety was shown
- Subjects :
- medicine.medical_specialty
Standard of care
business.industry
medicine.medical_treatment
medicine.disease
Clopidogrel
Internal medicine
Fibrinolysis
medicine
Cardiology
ST segment
cardiovascular diseases
Myocardial infarction
Cardiology and Cardiovascular Medicine
business
Ticagrelor
circulatory and respiratory physiology
medicine.drug
Subjects
Details
- ISSN :
- 07351097
- Volume :
- 73
- Database :
- OpenAIRE
- Journal :
- Journal of the American College of Cardiology
- Accession number :
- edsair.doi...........966c050d3d71b0eb77b8c6ee3c26a30a